365 related articles for article (PubMed ID: 15770608)
1. Biomedical applications of 10B and 11B NMR.
Bendel P
NMR Biomed; 2005 Apr; 18(2):74-82. PubMed ID: 15770608
[TBL] [Abstract][Full Text] [Related]
2. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
3. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
4. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
5. Combined TL and 10B-alanine ESR dosimetry for BNCT.
Bartolotta A; D'Oca MC; Lo Giudice B; Brai M; Borio R; Forini N; Salvadori P; Manera S
Radiat Prot Dosimetry; 2004; 110(1-4):627-30. PubMed ID: 15353720
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
7. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
[TBL] [Abstract][Full Text] [Related]
8. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields.
Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B
Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868
[TBL] [Abstract][Full Text] [Related]
9. A toolkit for epithermal neutron beam characterisation in BNCT.
Auterinen I; Serén T; Uusi-Simola J; Kosunen A; Savolainen S
Radiat Prot Dosimetry; 2004; 110(1-4):587-93. PubMed ID: 15353713
[TBL] [Abstract][Full Text] [Related]
10. 1H and 10B NMR and MRI investigation of boron- and gadolinium-boron compounds in boron neutron capture therapy.
Bonora M; Corti M; Borsa F; Bortolussi S; Protti N; Santoro D; Stella S; Altieri S; Zonta C; Clerici AM; Cansolino L; Ferrari C; Dionigi P; Porta A; Zanoni G; Vidari G
Appl Radiat Isot; 2011 Dec; 69(12):1702-5. PubMed ID: 21371896
[TBL] [Abstract][Full Text] [Related]
11. Physical and tumor biological aspects and calculation model of dosage in boron neutron capture therapy (BNCT).
Rassow J; Pöller F; Steinberg F; Meissner P
Strahlenther Onkol; 1993 Jan; 169(1):7-17. PubMed ID: 8434343
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro.
Pöller F; Sauerwein W
Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565
[TBL] [Abstract][Full Text] [Related]
13. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
14. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS.
Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL
J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the epithermal neutron beam for Boron Neutron Capture Therapy at the Brookhaven Medical Research Reactor.
Hu JP; Reciniello RN; Holden NE
Health Phys; 2004 May; 86(5 Suppl):S103-9. PubMed ID: 15069299
[TBL] [Abstract][Full Text] [Related]
17. Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT.
Hattori Y; Asano T; Niki Y; Kondoh H; Kirihata M; Yamaguchi Y; Wakamiya T
Bioorg Med Chem; 2006 May; 14(10):3258-62. PubMed ID: 16460951
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
[TBL] [Abstract][Full Text] [Related]
20. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
